Brief: PCI Biotech Q2 operating loss widens to NOK 9.3 million
Aug 30 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q2 operating loss 9.3 million Norwegian crowns ($1.1
million) versus loss 7.0 million crowns year ago
* Q2 pre-tax loss 9.2 million crowns versus loss 6.6 million
crowns year ago
Source text for Eikon: ID:nGNE9z18nR
Further company coverage: PCIB.OL
($1 = 8.2874 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process